Answers are grounded in this paper and cite their sources.
DA labels are prevalent among HAE patients but are frequently misdiagnosed and mislabelled. Misdiagnosed DA are associated with delay in HAE diagnosis as well as adverse clinical outcomes. Immunologists/allergists should consider pre-emptively reviewing and investigate every suspicious DA label, especially among HAE patients.
No takes yet. Share an insight, caveat, or question.
Wong et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: